Q1 2023 13F Holders as of 31 Mar 2023
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
34,246,696
-
Share change
-
-1,161,886
-
Total reported value
-
$33,405,987
-
Put/Call ratio
-
5.6%
-
Price per share
-
$0.98
-
Number of holders
-
60
-
Value change
-
-$1,152,067
-
Number of buys
-
18
-
Number of sells
-
28
Institutional Holders of PIERIS PHARMACEUTICALS INC - COM (PIRS) as of Q1 2023
As of 31 Mar 2023,
PIERIS PHARMACEUTICALS INC - COM (PIRS) was held by
60 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
34,246,696 shares.
The largest 10 holders included
Lynx1 Capital Management LP, BVF INC/IL, Aquilo Capital Management, LLC, Soleus Capital Management, L.P., MARSHALL WACE, LLP, CITADEL ADVISORS LLC, BlackRock Inc., VANGUARD GROUP INC, PLATINUM INVESTMENT MANAGEMENT LTD, and ACADIAN ASSET MANAGEMENT LLC.
This page lists
60
institutional shareholders reporting positions in this security
for the Q1 2023 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.